4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0000950170-25-034662
Chief Accounting Officer sold 571 shares at $6.29 ($3,592)
From the SEC's structured data for this filing
Trades in this filing
Abate Kristin · Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-04 | Sale : show line 1 in the form | −571 | $6.29 | $3,592 | 9,713 | D |
| Open-market sales · 571 sh · avg $6.29 · $3,592 | ||||||
Loading xslF345X05/ownership.xml…